Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited at the annual general meeting to be held on May 15, 2024, Board has recommended declaring dividends of an aggregate amount of RMB 985,802,593.28 on the basis of RMB 12.80 (inclusive of taxes) for every ten (10) shares in the capital of the Company. The proposed dividend is payable in respect of all issued ordinary shares in the capital of the Company as at the record date to be determined by the Company for the purposes of determining shareholders' entitlements to the final dividend.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Equities
600329
CNE000001808
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
35.8 CNY | +0.03% | -4.02% | +6.39% |
May. 15 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Directorate and Committee Changes | CI |
Apr. 30 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.39% | 3.29B | |
+43.31% | 6.19B | |
-16.99% | 4.48B | |
-13.10% | 3.12B | |
-4.17% | 2.5B | |
+45.47% | 1.94B | |
-9.11% | 1.68B | |
-2.09% | 1.64B | |
-12.50% | 1.56B | |
+47.56% | 1.54B |
- Stock Market
- Equities
- 600329 Stock
- News Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
- Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Recommends Dividend